• Identify the critical decision points in management of patients with depressive conditions, such as assessment (including assessment of unstable and high-risk conditions), empirically supported psycho therapies and pharmacological therapies, non-MDD conditions deserving consultation, patient education, and follow-up treatment.

• Accommodate local policies or procedures, such as those regarding referrals to or consultation with mental health personnel.

• Motivate administrators at each of the Federal agencies and care access sites to develop innovative plans to break down barriers that may prevent patients from having prompt access to preventive care.